These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8098078)

  • 1. First trimester topical tretinoin and congenital disorders.
    Jick SS; Terris BZ; Jick H
    Lancet; 1993 May; 341(8854):1181-2. PubMed ID: 8098078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.
    Loureiro KD; Kao KK; Jones KL; Alvarado S; Chavez C; Dick L; Felix R; Johnson D; Chambers CD
    Am J Med Genet A; 2005 Jul; 136(2):117-21. PubMed ID: 15940677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of first-trimester exposure to topical tretinoin: prospective cohort study.
    Shapiro L; Pastuszak A; Curto G; Koren G
    Lancet; 1997 Oct; 350(9085):1143-4. PubMed ID: 9343507
    [No Abstract]   [Full Text] [Related]  

  • 4. Tretinoin and pregnancy.
    Caron GA
    Lancet; 1993 Jun; 341(8861):1664. PubMed ID: 8100028
    [No Abstract]   [Full Text] [Related]  

  • 5. Is topical tretinoin safe during the first trimester?
    Shapiro L; Pastuszak A; Curto G; Koren G
    Can Fam Physician; 1998 Mar; 44():495-8. PubMed ID: 9559187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester exposure to topical tretinoin: its safety is not warranted.
    Martínez-Frías ML; Rodriguez-Pinilla E
    Teratology; 1999 Jul; 60(1):5. PubMed ID: 10413331
    [No Abstract]   [Full Text] [Related]  

  • 7. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
    MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.
    Thomseth V; Cejvanovic V; Jimenez-Solem E; Petersen KM; Poulsen HE; Andersen JT
    Acta Ophthalmol; 2015 Nov; 93(7):651-3. PubMed ID: 25923453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin analogues use in pregnancy among women with pregestational diabetes mellitus and risk of congenital anomaly: a retrospective population-based cohort study.
    Wang H; Wender-Ozegowska E; Garne E; Morgan M; Loane M; Morris JK; Bakker MK; Gatt M; de Walle H; Jordan S; Materna-Kiryluk A; Nelen V; Thys G; Wiesel A; Dolk H; de Jong-van den Berg LTW
    BMJ Open; 2018 Feb; 8(2):e014972. PubMed ID: 29478010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes after maternal exposure to fluconazole.
    Jick SS
    Pharmacotherapy; 1999 Feb; 19(2):221-2. PubMed ID: 10030772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple congenital defects associated with maternal use of topical tretinoin.
    Lipson AH; Collins F; Webster WS
    Lancet; 1993 May; 341(8856):1352-3. PubMed ID: 8098487
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical retinoids during pregnancy (continued).
    Prescrire Int; 2005 Jun; 14(77):100-1. PubMed ID: 15981398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy.
    De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M
    Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study.
    Sylvester GC; Khoury MJ; Lu X; Erickson JD
    Am J Public Health; 1994 Nov; 84(11):1757-60. PubMed ID: 7977913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsants and congenital malformations.
    Jick SS; Terris BZ
    Pharmacotherapy; 1997; 17(3):561-4. PubMed ID: 9165559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):29-39. PubMed ID: 18818179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.